Bright Minds Biosciences (DRUG)10% owner bought ~$4M
Cormorant Asset Management, 10% owner at Bright Minds Biosciences, bought ~$4M of Bright Minds Biosciences shares.
- ~$4M
- Approx. value · 184K sh @ $21.70
- 1.06M
- Holds after · shares reported
- Traded
- Nov 4, 2024
- Filed
- Nov 6, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 15, 2024Insider · 1 personInsiders: 8 purchases (~$2.1M)
- Oct 16, 2024Insider · 1 personInsiders: 3 purchases (~$1.2M)
- Nov 4, 2024 · this disclosureInsider10% owner purchased ~$4M of DRUG shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Bright Minds Biosciences
For Bright Minds Biosciences, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DRUG page.
Other recent filings by Cormorant Asset Management, LP, 10% owner
- SEC Form 4 at Bright Minds Biosciences (DRUG)Apr 30, 2026
- SEC Form 4 at Onkure Therapeutics (OKUR)May 19, 2025
- SEC Form 4 at Onkure Therapeutics (OKUR)May 14, 2025
- SEC Form 4 at Aardvark Therapeutics (AARD)Feb 19, 2025
- SEC Form 4 at Bright Minds Biosciences (DRUG)Oct 17, 2024
The full history of Cormorant Asset Management, LP, 10% owner is on the profile page.
How this filing works
Other disclosures at Bright Minds Biosciences
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRMay 29, 2026
- SEC Form 13F-HRMay 15, 2026
- SEC Form 4Apr 30, 2026
- SEC Form 13F-HRNov 14, 2025
- SEC Form 13F-HRAug 14, 2025
Everything OQRO holds on this company is on its DRUG page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data